Skip to main content

ASML Holding vs Pfizer: Founders, CEOs and History

ASML Holding was founded in 1984 by Philips Electronics, Arthur del Prado and is led by Christophe Fouquet. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.

Company facts

ASML Holding

Founded
1984
Headquarters
Veldhoven, Netherlands
Current CEO
Christophe Fouquet
Employees
44,209

Pfizer

Founded
1849
Headquarters
New York, New York
Current CEO
Albert Bourla
Employees
75,000

Founders

ASML Holding

  • Philips Electronics

    ASML was not founded by an individual with a vision. It was an underfunded joint venture between a conglomerate that wanted a project off its books and a smaller equipment company that wanted into lithography.

  • Arthur del Prado

    Del Prado contribution to ASML was structural and financial rather than technical.

ASML Holding founders in full

Pfizer

  • Charles Pfizer

    Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.

  • Charles Erhart

    Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…

Pfizer founders in full

CEOs and their tenures

ASML Holding

  1. Willem Maris1990–1999

    President and Chief Executive Officer

    Willem Maris was recruited from the Philips managerial ranks to run ASML in 1990, when the company was still loss-making and dependent on parent funding. His first task was keeping it solvent through the early 1990s downturn.

    Source
  2. Doug Dunn1999–2004

    President, Chief Executive Officer and Chairman of the Board

    Doug Dunn took over as president and chief executive on April 1, 1999 and ran ASML through the dot-com boom and the sharp semiconductor downturn that followed.

    Source
  3. Eric Meurice2004–2013

    President and Chief Executive Officer

    Eric Meurice was appointed president and chief executive effective October 1, 2004, joining from Thomson where he ran the television division.

    Source
  4. Peter Wennink2013–2024

    President and Chief Executive Officer

    Peter Wennink joined ASML as chief financial officer in 1999 after a career at Deloitte Accountants covering semiconductor clients, and became chief executive on July 1, 2013, leading the company jointly with technology chief Martin van den Brink.

    Source
  5. Christophe Fouquet2024–present

    President, Chief Executive Officer and Chair of the Board of Management

    Christophe Fouquet became president and chief executive on April 24, 2024, succeeding Peter Wennink and Martin van den Brink.

    Source
ASML Holding CEO history in full

Pfizer

  1. Ian Read2010–2018

    Chief Executive Officer

    He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.

    Source
  2. Albert Bourla2019–present

    Chairman and Chief Executive Officer

    A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.

    Source
  3. Dave Denton2022–2026

    Chief Financial Officer

    As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.

    Source
  4. Chris Boshoff2025–present

    Chief Scientific Officer and President, Research & Development

    He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.

    Source
  5. Cecile Guegan2026–present

    Interim Chief Financial Officer

    She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.

    Source
Pfizer CEO history in full

Timeline: ASML Holding and Pfizer side by side

  1. 1849Pfizer

    Pfizer Founded

    Charles Pfizer and Charles Erhart founded the company in Brooklyn.

  2. 1944Pfizer

    Penicillin Scale-Up

    Pfizer helped industrialize penicillin production during World War II.

  3. 1984ASML Holding

    Founded as ASM Lithography in Eindhoven

    ASM Lithography starts operations on April 1, 1984 as a joint venture between Philips and ASM International, with the mandate to commercialize the PAS 2000 wafer stepper developed inside Philips.

  4. 1986ASML Holding

    PAS 2500 stepper and the Carl Zeiss partnership

    ASML brings the PAS 2500 stepper to market with a new wafer alignment system developed by first chief scientist Steef Wittekoek, and establishes the optics partnership with Carl Zeiss that still supplies every ASML lithography system.

  5. 1988ASML Holding

    ASM International withdraws and Philips funds a rescue

    With few customers and heavy cash consumption, ASM International decides to stop funding the joint venture while Philips launches a company-wide cost-cutting program.

  6. 1991ASML Holding

    PAS 5500 platform turns the company around

    ASML launches the PAS 5500 platform, whose productivity and resolution win the first large orders from Intel and IBM under chief executive Willem Maris and take the company to profitability. PAS 5500 systems are still running in customer fabs decades later.

  7. 1995ASML Holding

    IPO in Amsterdam and on Nasdaq

    ASML becomes a fully independent public company with a dual listing on the Amsterdam Stock Exchange and Nasdaq. Philips sells half of its shares at the IPO and divests the remainder over the following years.

  8. 1998Pfizer

    Viagra Approved

    The FDA approved Viagra in 1998.

  9. 2000Pfizer

    Warner-Lambert Deal

    Pfizer acquired Warner-Lambert, adding Lipitor.

  10. 2001ASML Holding

    TWINSCAN platform launched and Silicon Valley Group acquired

    ASML introduces the TWINSCAN dual-stage architecture, which exposes one wafer while the next is measured and aligned, lifting throughput and overlay accuracy above competing systems.

  11. 2003ASML Holding

    First immersion lithography system

    The TWINSCAN AT:1150i debuts as ASML's first immersion machine, projecting 193 nanometer light through a layer of ultrapure water between the lens and the wafer to raise resolution.

  12. 2010ASML Holding

    First EUV prototype shipped

    ASML ships the TWINSCAN NXE:3100, its first extreme ultraviolet lithography tool, to the research facility of an Asian chipmaker.

  13. 2012ASML Holding

    Customer Co-Investment Program with Intel, TSMC and Samsung

    Intel, TSMC and Samsung acquire newly issued ASML shares equal to an aggregate 23 percent minority stake for ~$4.35 billion (3.85 billion euros) in cash, and separately commit ~$1.56 billion (1.38 billion euros) of R&D funding over five years dedicated to EUV…

  14. 2013ASML Holding

    Cymer acquisition completed and second-generation EUV shipped

    ASML completes the acquisition of Cymer, the San Diego supplier of the light sources used in its lithography systems, in a cash-and-stock deal valued at ~$2.2 billion (1.95 billion euros) when it was agreed in October 2012.

  15. 2017ASML Holding

    EUV enters high-volume manufacturing

    ASML begins shipping the production-ready TWINSCAN NXE:3400B after customers started ordering the NXE:3400 generation in batches in 2016, roughly two decades after EUV research began.

  16. 2019ASML Holding

    Dutch government stops EUV exports to China

    The Netherlands does not renew ASML's export licence for EUV systems to China, the start of a widening export control regime.

  17. 2019Pfizer

    Albert Bourla becomes CEO

    Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.

  18. 2020Pfizer

    BioNTech COVID Vaccine Partnership

    Pfizer and BioNTech brought Comirnaty through emergency authorization.

  19. 2023ASML Holding

    First High-NA EUV system shipped

    ASML ships the first of its next-generation EUV systems with a numerical aperture of 0.55, the TWINSCAN EXE:5000, to Intel in Hillsboro, Oregon.

  20. 2023Pfizer

    Seagen Acquisition

    Pfizer completed the $43 billion Seagen acquisition.

  21. 2024ASML Holding

    Christophe Fouquet becomes chief executive

    Peter Wennink and Martin van den Brink step down as presidents of ASML on April 24, 2024 and Christophe Fouquet becomes president, chief executive officer and chair of the Board of Management.

  22. 2025ASML Holding

    Record year, first EXE:5200B and Mistral AI investment

    ASML reports total net sales of ~$37 billion (32.7 billion euros), up 15.6 percent, net income of ~$10.8 billion (9.6 billion euros), a gross margin of 52.8 percent and 535 systems sold, and closes the year with a backlog of ~$43.8 billion (38.8 billion euros)…

  23. 2025Pfizer

    Chris Boshoff Becomes CSO

    Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.

  24. 2025Pfizer

    Metsera Acquisition

    Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.

  25. 2025Pfizer

    FY2025 Revenue Base

    Pfizer reported $62.579 billion of FY2025 revenue.

  26. 2026Pfizer

    Innovent Oncology Collaboration

    Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.

Acquisitions

ASML Holding

  • Berliner Glas Group2020Undisclosed
  • Hermes Microvision Inc. (HMI)2016$3.1B
  • Cymer Inc.2013$2.6B
  • Brion Technologies2007$270M
  • Silicon Valley Group (SVG)2001$1.6B
All ASML Holding acquisitions

Pfizer

  • Metsera, Inc.2025$7B
  • Seagen Inc.2023$43B
  • Medivation Inc.2016$14B
  • Wyeth2009$68B
  • Pharmacia Corporation2003$60B
  • Warner-Lambert Company2000$111B
All Pfizer acquisitions

Questions about ASML Holding vs Pfizer

Who is the CEO of ASML Holding NV and Pfizer Inc.?

ASML Holding NV is led by Christophe Fouquet and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was ASML Holding NV founded vs Pfizer Inc.?

Pfizer Inc. was founded in 1849 — 135 years before ASML Holding NV, which was founded in 1984. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger ASML Holding NV.

How many employees does ASML Holding NV have compared to Pfizer Inc.?

ASML Holding NV employs approximately 44,209 people, while Pfizer Inc. employs approximately 75,000. Pfizer Inc. has the larger workforce at 75,000 employees, compared to ASML Holding NV's 44,209. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are ASML Holding NV and Pfizer Inc. headquartered?

ASML Holding NV is headquartered in Netherlands and Pfizer Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded ASML Holding NV and Pfizer Inc.?

ASML Holding NV was founded by Philips Electronics, Arthur del Prado. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.

Which company has a longer operating history — ASML Holding NV or Pfizer Inc.?

Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. ASML Holding NV has been in operation for around 42 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the ASML Holding vs Pfizer overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.